Dr. Reddy's Labs Files 6-K, Submits Form 20-F
Ticker: RDY · Form: 6-K · Filed: Aug 14, 2024 · CIK: 1135951
Sentiment: neutral
Topics: disclosure, sec-filing, annual-report
TL;DR
DRL filed a 6-K, confirming they're submitting their 20-F. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 14, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its annual report under Form 20-F.
Why It Matters
This filing is a routine disclosure for foreign private issuers, confirming their adherence to reporting requirements with the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Filer
- 20240814 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as a foreign private issuer and to indicate that the registrant is submitting its annual report under cover of Form 20-F.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on August 14, 2024.
What is the Central Index Key (CIK) for Dr. Reddy's Laboratories Ltd?
The Central Index Key (CIK) for Dr. Reddy's Laboratories Ltd is 0001135951.
What is the standard industrial classification for Dr. Reddy's Laboratories Ltd?
The standard industrial classification for Dr. Reddy's Laboratories Ltd is Pharmaceutical Preparations [2834].
Does Dr. Reddy's Laboratories Ltd file its annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Ltd indicates it files its annual reports under cover of Form 20-F.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.6 · Accepted 2024-08-14 10:05:22
Filing Documents
- drr0659_6k.htm (6-K) — 14KB
- drr0659_ex99-1.htm (EX-99.1) — 10KB
- drr0659_ex99-1img01.jpg (GRAPHIC) — 10KB
- drr0659_ex99-1img02.jpg (GRAPHIC) — 14KB
- drr0659_ex99-1img03.jpg (GRAPHIC) — 1556KB
- drr0659_ex99-1img04.jpg (GRAPHIC) — 1455KB
- 0001575872-24-000911.txt ( ) — 4204KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 14, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3